245 filings
Page 9 of 13
424B3
autv3mgd32b 4b
22 Aug 22
Prospectus supplement
5:13pm
8-K
a0dt1dic
22 Aug 22
Results of Operations and Financial Condition
5:08pm
8-K
1lf78jjf
16 Aug 22
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
4:01pm
NT 10-Q
0gcb ft10j27ec
15 Aug 22
Notice of late quarterly filing
5:59pm
424B3
oxvucapra7svq0n3ajd
12 Aug 22
Prospectus supplement
5:30pm
8-K
mmbqfs2646h2ykgz
12 Aug 22
Entry into a Material Definitive Agreement
5:04pm
424B3
r2ezc94vfna
2 Aug 22
Prospectus supplement
9:35am
8-K
z9t12p
2 Aug 22
Allarity Therapeutics Refocuses Oncology Pipeline Strategy Towards Combination Therapies
9:33am
424B3
2jl tsals
11 Jul 22
Prospectus supplement
5:16pm
8-K
xw9 9nrb3gxk6e
11 Jul 22
Departure of Directors or Certain Officers
4:05pm
424B3
to6wpl rnz7j9e
30 Jun 22
Prospectus supplement
6:34am
8-K
i35fk od88
29 Jun 22
Allarity Therapeutics Announces Executive Leadership Transition
7:44pm
8-K
tb5kqsokowixmd4yqnkj
10 Jun 22
Entry into a Material Definitive Agreement
4:01pm
424B3
3etwqsnn34rv091v0b
7 Jun 22
Prospectus supplement
5:26pm
EFFECT
odo c10kv8amq
7 Jun 22
Notice of effectiveness
12:15am
POS AM
cuhp28g n4mwlhr4dmxc
2 Jun 22
Prospectus update (post-effective amendment)
7:58pm
8-K
5gdom8zx
27 May 22
Allarity Therapeutics Reports First Quarter 2022 Financial Results
5:29pm
8-K
nckjo hz6a9bgf
27 May 22
Regulation FD Disclosure
6:01am
8-K/A
k62w2q l4uflfd
19 May 22
Correction Notice to Press Release Announcing Financial Results For the Fourth Quarter and Full Year 2021 Financial Results and Corporate Update
6:05am